"Ophthalmic Consultants of Connecticut (OCC) in Meriden is staffed with eye doctors who specialize in a range of subspecialties for comprehensive eye care. We offer the full gamut of services, from routine eye exams to complex treatments for eye diseases to elective cosmetic procedures."

During the past decade, Ophthalmic Consultants of Connecticut conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ophthalmic Consultants of Connecticut" are "Bacterial Conjunctivitis" (1 trials) and "Primary Open-angle Glaucoma" (1 trials). Many other conditions were trialed in "Ophthalmic Consultants of Connecticut" in a lesser frequency.

Most popular intervention types in "Ophthalmic Consultants of Connecticut" are "Device" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "PRESERFLO® MicroShunt" (1 trials), "PVP-I 0.6%" (1 trials), "Placebo" (1 trials), "SHP640" (1 trials) and "Trabeculectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmic Consultants of Connecticut" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmic Consultants of Connecticut". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ophthalmic Consultants of Connecticut, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmic Consultants of Connecticut, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".